N-[3-[4-[4-(1-methylcyclobutanecarbonyl)piperazine-1-carbonyl]cyclohexyl]cyclohexyl]cyclopropanecarboxamide
C27H43N3O3 — CID 153420716
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[4-[4-(1-methylcyclobutanecarbonyl)piperazine-1-carbonyl]cyclohexyl]cyclohexyl]cyclopropanecarboxamide
N-[3-[4-[4-(1-methylcyclobutanecarbonyl)piperazine-1-carbonyl]cyclohexyl]cyclohexyl]cyclopropanecarboxamide (PubChem CID 153420716) has the molecular formula C27H43N3O3 and a molecular weight of 457.66 g/mol. Its IUPAC name is N-[3-[4-[4-(1-methylcyclobutanecarbonyl)piperazine-1-carbonyl]cyclohexyl]cyclohexyl]cyclopropanecarboxamide.
Molecular Properties
| Compound Name | N-[3-[4-[4-(1-methylcyclobutanecarbonyl)piperazine-1-carbonyl]cyclohexyl]cyclohexyl]cyclopropanecarboxamide |
|---|---|
| PubChem CID | 153420716 |
| Molecular Formula | C27H43N3O3 |
| Molecular Weight | 457.66 g/mol |
| Exact Mass | 457.33 |
| IUPAC Name | N-[3-[4-[4-(1-methylcyclobutanecarbonyl)piperazine-1-carbonyl]cyclohexyl]cyclohexyl]cyclopropanecarboxamide |
| SMILES | CC1(C(=O)N2CCN(C(=O)C3CCC(C4CCCC(NC(=O)C5CC5)C4)CC3)CC2)CCC1 |
| InChI | InChI=1S/C27H43N3O3/c1-27(12-3-13-27)26(33)30-16-14-29(15-17-30)25(32)21-10-6-19(7-11-21)22-4-2-5-23(18-22)28-24(31)20-8-9-20/h19-23H,2-18H2,1H3,(H,28,31) |
| InChIKey | UKEKVAOFHZJMBO-UHFFFAOYSA-N |
| XLogP | 3.74 |
| TPSA | 69.72 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.66 |
| LogP ≤ 5 | 3.74 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153420716 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.